Breaking News
Taoping Inc Achieves Impressive Growth in Contract Revenue Driven by AI and Smart City Solutions
On February 7, 2024, Taoping Inc. (NASDAQ: TAOP) announced an impressive achievement with a remarkable 78% year-over-year growth in contract...
Roblox Corp RBLX Reports Impressive Q4 Results and Positive Outlook
On February 7, 2024, Roblox Corp (RBLX) announced impressive Q4 results that had a significant impact on its stock price,...
Beamr Imaging Ltd Introduces Groundbreaking Cloud Service for Video Processing
On February 20, 2024, at 1:00pm EST, Beamr Imaging Ltd. will be unveiling an innovative cloud service that aims to...
Perion Networks Stock Faces Downturn Despite Impressive Q4 Results
Perion Network's stock is experiencing a downturn today as its full-year 2024 forecast falls short of expectations, despite impressive Q4...
Biodexas Groundbreaking Compound Tolimidone Revolutionizing Type 1 Diabetes Treatment
On February 7, 2024, Biodexa made an exciting announcement regarding the allowance of a U.S. patent for their groundbreaking compound,...
One Stop Systems Inc Ships Gen 5 4U Pro Accelerator System to Prominent Provider of Composable Infrastructure
As of February 7, 2024, One Stop Systems, Inc. (OSS) has commenced the shipment of its cutting-edge Gen 5 4U...
Herc Holdings Increases Quarterly Dividend by 5 to Reward Shareholders
Herc Holdings, a leading company in its industry, has recently announced a remarkable development for its shareholders. Effective February 7,...
Evaxion Biotech AS Regains Compliance with Nasdaq Listing Rule 5550a2
Evaxion Biotech A/S (NASDAQ:EVAX) has successfully fulfilled the minimum bid price requirement outlined by the Nasdaq Listing Rule 5550(a)(2), marking...
Goldman Sachs Analyst Maintains Sell Rating on Overvalued HR Block
On February 7, 2024, George Kelly, an analyst at Goldman Sachs, expressed a pessimistic view on H&R Block (NYSE:HRB). Despite...
Atossa Therapeutics Successfully Fills ZEndoxifen Segment of ISPY 2 Clinical Trial
As of February 7, 2024, Atossa Therapeutics has successfully filled the (Z)-endoxifen segment of the I-SPY 2 clinical trial. This...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
Synopsys Shares Plummet Amid Fraud Allegations and Disappointing Earnings
